X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Acta Pharmaceutica Sinica B

期刊標題檢索 ACTA PHARM SIN 最新評論: So far, there has been no change. (2026-04-14)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Acta Pharmaceutica Sinica B]您好,您是該頁面的第 331172 位訪客。

期刊簡介
期刊名稱Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B
LetPub Score
8.3
51 ratings
Rate

Reputation
8.9

Influence
7.6

Speed
8.7

期刊簡稱ACTA PHARM SIN B
ISSN2211-3835
E-ISSN2211-3843
h-index28
CiteScore
CiteScoreSJRSNIPCiteScore Rank
24.303.4892.465
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: General Pharmacology, Toxicology and Pharmaceutics
Q11 / 77

自引率 (2023-2024)6.10%自引率趨勢
掲載範囲
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association
Peer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association

Acta Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.

APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chineses Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.
官方網站https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b
在線稿件提交https://www.editorialmanager.com/apsb/default.aspx
開放訪問Yes
出版商Elsevier BV
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區CHINA MAINLAND
發行頻率月刊
創刊年2011
每年文章數308每年文章數趨勢
黃金OA百分比99.44%
OA Related Info
APC: Yes( Full Length Articles and Reviews - USD2600; Short Articles - USD2000; )
APC waiver:Check Notes
Other charges: No
Keywords: pharmaceutical science、traditional chinese medicine、pharmaceutics、pharmaceutical chemistry、pharmacokinetics
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ16/352
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835%5BISSN%5D
平均審稿時間 *來自出版商的數據: Submission to first decision: 8 days; Review time: 36 days; Submission to Accept: 134 days; Acceptance to publication: 7 days;
來自作者的數據: 19 Weeks
競爭力 *來自作者的數據:
來自Elsevier的數據: 9%
參考鏈接
相關期刊 【Acta Pharmaceutica Sinica B】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Antibiotics-BaselH-index: 0

    CiteScore: 8.70
    Pharmacology Research & PerspectivesH-index: 0

    CiteScore: 5.60
    Therapeutics and Clinical Risk ManagementH-index: 0

    CiteScore: 4.60
    Revista Brasileira de Farmacognosia-Brazilian Journal of PharmacognosyH-index: 37

    CiteScore: 2.90
    Infarma Pharmaceutical SciencesH-index: 0

    CiteScore: 0.20
    Mental Health ClinicianH-index: 0

    CiteScore: 2.10
    Pharmacological Research Modern Chinese MedicineH-index: 0

    CiteScore: 3.40
    學科內最受檢索的期刊 頁面查看次數
    Antibiotics-Basel35734
    Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy23768
    Pharmacology Research & Perspectives19301
    Therapeutics and Clinical Risk Management8746
    Pharmacological Research Modern Chinese Medicine4959
    Infarma Pharmaceutical Sciences3226
    Mental Health Clinician2090
  •  

    Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/10)
  [Acta Pharmaceutica Sinica B] 的評論撰寫評論
作者: yijinsha


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-14 00:17:23 評論於
So far, there has been no change.
(0) 讚! | yijinsha

作者: Javen.Wu


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-13 23:26:44 評論於
I have been with the editor for one month.
(0) 讚! | Javen.Wu

作者: 开开开开放


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-13 17:13:23 評論於
How are you guys doing? It's been more than ten days and still no news.
(0) 讚! | 开开开开放

作者: 开开开开放


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-13 17:12:51 評論於
The first decision of the homepage was made 6 days ago, and now it's been more than ten days, right?
(0) 讚! | 开开开开放

作者: yijinsha


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-02 06:46:22 評論於
Did you submit it for review later?
(0) 讚! | yijinsha

作者: yijinsha


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-02 06:45:23 評論於
How are you doing? It's been 18 days with editor. Please reject the template quickly!
(0) 讚! | yijinsha

作者: dingdongdong


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-02-25 17:59:11 評論於
I have been studying for two months just like you. My status hasn't changed. How about you?
(0) 讚! | dingdongdong

作者: 进击的乌龟王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-02-14 12:17:19 評論於
Submitted WE on February 7th, unchanged to this day.
(0) 讚! | 进击的乌龟王

作者: HBC_BJ


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-02-08 16:18:05 評論於
Can I send a letter to urge in the middle? It's been 18 days with the editor...
(0) 讚! | HBC_BJ

作者: HBC_BJ


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-02-08 16:17:24 評論於
May I ask if it is possible to send a letter to urge the editor? It has been 18 days...
(0) 讚! | HBC_BJ

作者: acceptacceptjm


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-11-07 14:10:28 評論於
May I ask how long it takes for the updated version to be released by the editor after the second review of the RRC? It has been more than twenty days since it was held by the editor.
(0) 讚! | acceptacceptjm

作者: 晨薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-10-20 07:40:10 評論於
May I ask how long it will take for the submission to be reviewed and what the outcome will be?
(0) 讚! | 晨薇

作者: 快乐风


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2025-10-14 18:49:45 評論於
Hello, may I ask what format needs to be modified? The email did not specify, please let me know specifically which format needs to be changed.
(0) 讚! | 快乐风

作者: 快乐风


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2025-10-14 18:48:28 評論於
Hello, may I ask which formats need to be modified? The editor only asked us to make changes without specifying what needs to be changed.
(0) 讚! | 快乐风

作者: 半塘小子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-28 21:34:43 評論於
8.22: Submission, directly with editor
8.25: Official website updated, review status not updated
8.28: Under review, invited 4 reviewers
(0) 讚! | 半塘小子

作者: liu pei pei


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-11 10:25:24 評論於
The submission was made on July 8, 2025, but there has been no news yet. I would like to ask senior brothers and sisters, how long does it usually take for the first reply?
(0) 讚! | liu pei pei

作者: dingdongdong


領域: 综合性期刊
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-02 16:10:36 評論於
Original: 楼主,最后怎么样啊?

Translation: OP, how did it go in the end?
(0) 讚! | dingdongdong

作者: yazai


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-16 17:09:42 評論於
After rework, what does it mean that "decision in progress" by editor10 for over 10 days?
(0) 讚! | yazai

作者: 哈哈哈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-12-20 12:37:04 評論於
Are you still in WE now?
(0) 讚! | 哈哈哈

作者: qty


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-29 14:58:44 評論於
It has been 10 days with the editor.
(0) 讚! | qty

作者: asd3204


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2024-11-07 22:47:41 評論於
You can submit something else, no problem. Anything sent directly to the editor after the deadline will be rejected, without exception.
(0) 讚! | asd3204

作者: Tan-Xin


領域: 材料科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-03 16:24:21 評論於
After submission, it was with the editor. Then it was DIP. Does this mean it has been rejected, and can I prepare to submit to other journals?
(0) 讚! | Tan-Xin

作者: 一条小春豪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-19 21:00:44 評論於
Friend, has your status changed? I am also DIP now.
(0) 讚! | 一条小春豪

作者: 龙鳞新峰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 16:56:02 評論於
Please translate the following passage into English: None
(0) 讚! | 龙鳞新峰

作者: 辉666


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-12 10:18:37 評論於
How long does the with editor stage last?
(1) 讚! | 辉666

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/10)

開始撰寫 [Acta Pharmaceutica Sinica B] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*